X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Nasal Spray Shows Its Effect Against New COVID Variants

    Mid-Point Regulatory Science Strategy Study Published By EMA

    AADC Inadequacy To Be Handled By A Novel Gene Therapy

    New Drug Explored For Epilepsy Gets $3M Funding In Australia

    Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials

    Faster Clinical Trial Nods Planned By The UK To Curb Issues

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    U.S. FDA Approves DARZALEX Split-Dosing Regimen

    EMA Keeping A Close Watch On Critical Medicine Shortages

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Efficacy Shown On Cystic Fibrosis Patients In 4-Year Study

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Nasal Spray Shows Its Effect Against New COVID Variants

    Mid-Point Regulatory Science Strategy Study Published By EMA

    AADC Inadequacy To Be Handled By A Novel Gene Therapy

    New Drug Explored For Epilepsy Gets $3M Funding In Australia

    Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials

    Faster Clinical Trial Nods Planned By The UK To Curb Issues

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    U.S. FDA Approves DARZALEX Split-Dosing Regimen

    EMA Keeping A Close Watch On Critical Medicine Shortages

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Efficacy Shown On Cystic Fibrosis Patients In 4-Year Study

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home News

The US Intends To Implement Federal Employee Vaccination Law

Content Team by Content Team
12th April 2022
in News
The UK begins the biggest ever immunization program

The Justice Department petitioned a federal appeals court on April 11 to enable the Biden administration to begin implementing a federal employee immunisation mandate that was stopped by a lower court judge in January.

President Joe Biden’s executive order ordering that government civilian employees be inoculated against COVID-19 was reinstated by a panel of the 5th U.S. Circuit Court of Appeals. Until the court takes further procedural steps, the White House advised federal agencies this week that they should continue to take no actions to enforce or execute the COVID-19 vaccination requirement.

The Justice Department urged the appeals court on Monday to take the necessary steps to allow the government to resume enforcing President Joe Biden’s executive order. It said that the appeals court should make its decision as soon as possible so that the ruling can take effect. It said that the damage to the public interest and the government shows that this is the right thing to do.

Biden announced in September that he would order roughly 3.5 million federal employees to get immunised by Nov. 22 unless they have a religious or medical exemption, or face penalty or dismissal. The administration claimed that the federal trial court lacked jurisdiction over the case. Employees were required to file a grievance under the Civil Service Reform Act, it told the appeals court (CSRA).

According to the panel’s 2-1 ruling, the plaintiffs attempted to evade the CSRA’s exclusive review scheme. More than 93 percent of government workers have gotten at least one vaccination, with 98 percent having been vaccinated or requesting a religious or medical exemption, as per the White House.

Biden’s COVID-19 vaccination-or-testing rule for major corporations was halted by the US Supreme Court in mid-January. A varied federal vaccine mandate for healthcare establishments was approved by the court. In December, a federal judge delayed a third major vaccine demand targeted at employees of government contractors such as airlines and manufacturers.

Previous Post

NICE Asks Gilead To Lower Trodelvy Rate And Bans Eczema Meds

Next Post

Aptar Pharma Returns In-Person to Pharmapack 2022 as Premium Partner to Showcase Expanded Drug Delivery Solutions Offering

Related Posts

Drug Development

Nasal Spray Shows Its Effect Against New COVID Variants

27th March 2023
FDA Approvals

Mid-Point Regulatory Science Strategy Study Published By EMA

27th March 2023
Drug Development

AADC Inadequacy To Be Handled By A Novel Gene Therapy

24th March 2023
Drug Development

New Drug Explored For Epilepsy Gets $3M Funding In Australia

23rd March 2023
Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials
Clinical Trials

Faster Clinical Trial Nods Planned By The UK To Curb Issues

22nd March 2023
Pharma Drugs Gain From Tardigrade Proteins, Says Research
Drug Development

Pharma Drugs Gain From Tardigrade Proteins, Says Research

22nd March 2023
Next Post
Aptar Pharma Returns In-Person to Pharmapack 2022 as Premium Partner to Showcase Expanded Drug Delivery Solutions Offering

Aptar Pharma Returns In-Person to Pharmapack 2022 as Premium Partner to Showcase Expanded Drug Delivery Solutions Offering

Latest News

Drug Development

Nasal Spray Shows Its Effect Against New COVID Variants

27th March 2023
FDA Approvals

Mid-Point Regulatory Science Strategy Study Published By EMA

27th March 2023
Drug Development

AADC Inadequacy To Be Handled By A Novel Gene Therapy

24th March 2023
Drug Development

New Drug Explored For Epilepsy Gets $3M Funding In Australia

23rd March 2023
Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials
Clinical Trials

Faster Clinical Trial Nods Planned By The UK To Curb Issues

22nd March 2023
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In